{{Rsnum
|rsid=8057044
|Gene=FTO
|Chromosome=16
|position=53778702
|Orientation=plus
|GMAF=0.4633
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Summary=Associated in African Americans, but not non-Hispanic whites, with adiposity
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FTO
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.4 | 53.1 | 19.5
| HCB | 5.8 | 29.9 | 64.2
| JPT | 4.5 | 42.0 | 53.6
| YRI | 63.9 | 30.6 | 5.4
| ASW | 50.9 | 42.1 | 7.0
| CHB | 5.8 | 29.9 | 64.2
| CHD | 5.5 | 36.7 | 57.8
| GIH | 10.9 | 45.5 | 43.6
| LWK | 53.2 | 37.6 | 9.2
| MEX | 5.2 | 50.0 | 44.8
| MKK | 52.3 | 41.3 | 6.5
| TSI | 27.5 | 48.0 | 24.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=20379142
|Title=Association of FTO Gene Variants With Adiposity in African-American Adolescents.
}}

{{PMID Auto
|PMID=19322589
|Title=Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.
|OA=1
}}

{{PMID Auto
|PMID=21102551
|Title=Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic Insulin Resistance Atherosclerosis Study cohort.
}}

{{on chip | Affy GenomeWide 6}}